Global Isothermal Nucleic Acid Amplification Technology Market - 2023-2030
The Global Isothermal Nucleic Acid Amplification Technology Market reached USD 3.3 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 7.5 billion by 2030. the isothermal nucleic acid amplification technology market is expected to exhibit a CAGR of 11.1% during the forecast period 2023-2030.
Isothermal nucleic acid amplification is a technique that quickly and effectively collects nucleic acid series at a consistent temperature. Nucleic acid amplification technologies are employed in molecular biology and recombinant DNA approaches. These methods are employed as top practices in identifying and investigating a short number of nucleic acids.
Market Dynamics
The Growing Prevalence of Infectious Diseases Globally is Driving the Global Isothermal Nucleic Acid Amplification Technology Market in the Forecast Period.
The growing prevalence of infectious diseases globally is driving the global isothermal nucleic acid amplification technology (INAAT) market growth during the forecast period. For instance, the World Health Organization registered over 5,000 fresh monkeypox patients between October 24, 2022 to November 23, 2022. Moreover, at the end of 2021, over 11.7 million individuals were on Anti Retroviral Treatment (ART) outcome of the CDC’s aid for HIV care and treatment via the U.S. President’s Emergency Plan for AIDS Response.
The Growing Geriatric Population is Providing the Global Isothermal Nucleic Acid Amplification Technology Market With Prospective Growth Opportunities.
The growing geriatric population is presenting the global isothermal nucleic acid amplification market with prospective growth opportunities in the upcoming years. For instance, according to the World Population Prospects 2022, from the UN, the number of individuals aged 80 or above is anticipated to grow triple fold, from 157 million in 2022 to 459 million by 2050.
COVID-19 Impact Analysis
The COVID-19 analysis includes Pre-COVID Scenario, COVID Scenario, and Post-COVID Scenario along with Pricing Dynamics (Including pricing change during and post-pandemic comparing it to pre-COVID scenarios), Demand-Supply Spectrum (Shift in demand and supply owing to trading restrictions, lockdown and subsequent issues), Government Initiatives (Initiatives to revive market, sector or Industry by Government Bodies) and Manufacturers Strategic Initiatives (What manufacturers did to mitigate the COVID issues will be covered here).
Russia-Ukraine War Impact Analysis
The war has negatively impacted the global isothermal nucleic acid amplification market to a slight extent as the WHO has recorded 703 attacks on health infrastructure since Russia's attack started. Moreover, as Russian armed forces progress deeper into the heart of neighboring Ukraine, costs of key raw materials such as aluminum, copper, steel and plastic, separated from general inflation, are currently threatening additional cost escalation for white goods commodities. However, despite the War, Ukraine continues to provide necessary health services to patients.
Global Recession Impact Analysis
The healthcare industry is not completely immune to recession, as healthcare institutions thought firings and employment during past financial downturns. That stated, the industry does cope finer than other sectors because of its essential nature. However, the danger of recession threatens the market as inflation persists increasing.
The elevated extent of tension about the persistent recession as the high inflation in developed countries worldwide has transpired in a general cost surge over the past two years. The cumulatively deteriorating general purchasing control is anticipated to affect growing economies particularly and is considered helpful in numerous ways.
Artificial Intelligence Impact Analysis
Artificial intelligence is estimated to have a positive impact on the global isothermal nucleic acid amplification market in the upcoming years. The combination of artificial intelligence (AI) and Internet of Things (IoT) technology (AIoT) may be the biggest disruption to the isothermal nucleic acid amplification since the invention of the first commercial ice-making machine two centuries ago.
Segment Analysis
The global isothermal nucleic acid amplification technology market is segmented based on product type, applications, technology and region.
The Loop-mediated Isothermal Amplification (LAMP) Technology Type Segment is Expected to Hold a Dominant Position in the Market Over the Forecast Period.
Loop-mediated Isothermal Amplification (LAMP) is estimated to hold 28.6% of the market share by 2030 owing to the increasing product introductions into the market. For instance, in March 2022, Thermo fisher scientific, an American supplier of scientific instrumentation, reagents and consumables and software services, introduced two new reverse transcription loop-mediated isothermal amplification-based developments that deliver a rapid and inexpensive technique for identifying viral pathogens.
Geographical Analysis
Europe is Estimated to Hold the Second-largest Share of the Global Isothermal Nucleic Acid Amplification Technology Market During the Forecast Period.
Owing to the increasing number of cancer deaṭhs and growing efforts to fight against cancer Europe is estimated to hold around 25.9% of the global isothermal nucleic acid amplification market by 2030. For instance, according to the 2022 edition of Health at a Glance, cancer is the second greatest reason for death in the EU behind cardiovascular disorders.
Between 30‑50% of cancer patients' deaths are avoidable and mortality can also be reduced through earlier detection and the condition of better punctual and effective therapies. Europe’s Beating Cancer Plan strives to decrease the load of cancer and manage cancer-related imbalances between and within nations, with efforts to help, coordinate and complete the actions of Member States.
Competitive Landscape
The major global players in the market include bioMerieux, Becton, Dickinson & Company, Lucigen, Qiagen, Quidel Corporation, Eiken Chemical Co. Ltd, Tecan Genomics Inc., Meridian Bioscience, OptiGene Limited and Thermo Fisher Scientific among others.
Why Purchase the Report?
• To visualize the global isothermal nucleic acid amplification technology market segmentation based on product type, applications, technology, end user, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of isothermal nucleic acid amplification technology market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.
The Global Isothermal Nucleic Acid Amplification Technology Market Report Would Provide Approximately 53 Tables, 54 Figures and 195 Pages.
Target Audience 2023
• Manufacturers / Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies
- 1. Methodology and Scope
- 1.1. Research Methodology
- 1.2. Research Objective and Scope of the Report
- 2. Definition and Overview
- 3. Executive Summary
- 3.1. Snippet by Product Type
- 3.2. Snippet by Applications
- 3.3. Snippet by Technology
- 3.4. Snippet by End User
- 4. Dynamics
- 4.1. Impacting Factors
- 4.1.1. Drivers
- 4.1.1.1. Rising Demand for Isothermal Nucleic Acid Amplification Technology for Storage Purposes
- 4.1.1.2. Market Developments.
- 4.1.2. Restraints
- 4.1.2.1. The Growing Trend of Using Refurbished Equipment
- 4.1.3. Opportunity
- 4.1.4. Government Initiatives
- 4.1.5. Impact Analysis
- 5. Industry Analysis
- 5.1. Porter's Five Force Analysis
- 5.2. Regulatory Analysis
- 5.3. Pricing Analysis
- 5.4. Patent Analysis
- 5.5. PEST Analysis
- 6. COVID-19 Analysis
- 6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario After COVID-19
- 6.1.3. Scenario Post COVID-19
- 6.2. Pricing Dynamics Amid COVID-19
- 6.3. Demand-Supply Spectrum
- 6.4. Government Initiatives Related to the Market During the Pandemic
- 6.5. Manufacturers’ Strategic Initiatives
- 6.6. Conclusion
- 7. Russia-Ukraine War Analysis
- 8. Global Recession Analysis
- 9. Artificial Intelligence Impact Analysis
- 10. By Product Type
- 10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.1.2. Market Attractiveness Index, By Product Type
- 10.2. Instruments
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 10.3. Reagents
- 11. By Applications
- 11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
- 11.1.2. Market Attractiveness Index, By Applications
- 11.2. Infectious Diseases Diagnostics*
- 11.2.1. Introduction
- 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 11.3. Blood Screening
- 11.4. Cancer Research
- 11.5. Others
- 12. By Technology
- 12.1. Introduction
- 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 12.1.2. Market Attractiveness Index, By Technology
- 12.2. Nucleic Acid Sequence-based Amplification (NASBA)
- 12.2.1. Introduction
- 12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 12.3. Single Primer Isothermal Amplification (SPIA)
- 12.4. Nicking Enzyme Amplification Reaction (NEAR)
- 12.5. Helicase-dependent Amplification (HDA)
- 12.6. Transcription Mediated Amplification (TMA)
- 12.7. Loop-mediated Isothermal Amplification (LAMP)
- 12.8. Strand Displacement Amplification (SDA)
- 12.9. Others
- 13. By End User
- 13.1. Introduction
- 13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 13.1.2. Market Attractiveness Index, By End User
- 13.2. Hospitals and Clinics
- 13.2.1. Introduction
- 13.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 13.3. Diagnostic Center
- 13.4. Research Laboratories
- 13.5. Others
- 14. By Region
- 14.1. Introduction
- 14.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 14.1.2. Market Attractiveness Index, By Region
- 14.2. North America
- 14.2.1. Introduction
- 14.2.2. Key Region-Specific Dynamics
- 14.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 14.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
- 14.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 14.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 14.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 14.2.7.1. The U.S.
- 14.2.7.2. Canada
- 14.2.7.3. Mexico
- 14.3. Europe
- 14.3.1. Introduction
- 14.3.2. Key Region-Specific Dynamics
- 14.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 14.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
- 14.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 14.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 14.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 14.3.7.1. Germany
- 14.3.7.2. The U.K.
- 14.3.7.3. France
- 14.3.7.4. Italy
- 14.3.7.5. Spain
- 14.3.7.6. Rest of Europe
- 14.4. South America
- 14.4.1. Introduction
- 14.4.2. Key Region-Specific Dynamics
- 14.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 14.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
- 14.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 14.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 14.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 14.4.7.1. Brazil
- 14.4.7.2. Argentina
- 14.4.7.3. Rest of South America
- 14.5. Asia-Pacific
- 14.5.1. Introduction
- 14.5.2. Key Region-Specific Dynamics
- 14.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 14.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
- 14.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 14.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 14.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 14.5.7.1. China
- 14.5.7.2. India
- 14.5.7.3. Japan
- 14.5.7.4. Australia
- 14.5.7.5. Rest of Asia-Pacific
- 14.6. Middle East and Africa
- 14.6.1. Introduction
- 14.6.2. Key Region-Specific Dynamics
- 14.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 14.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
- 14.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 14.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 15. Competitive Landscape
- 15.1. Competitive Scenario
- 15.2. Market Share Analysis
- 15.3. Mergers and Acquisitions Analysis
- 16. Company Profiles
- 16.1. Thermo Fisher Scientific Inc.
- 16.1.1. Company Overview
- 16.1.2. Product Type Portfolio and Description
- 16.1.3. Financial Overview
- 16.1.4. Key Developments
- 16.2. bioMerieux
- 16.3. Becton, Dickinson & Company
- 16.4. Lucigen
- 16.5. Qiagen
- 16.6. Quidel Corporation
- 16.7. Eiken Chemical Co. Ltd
- 16.8. Tecan Genomics Inc.
- 16.9. Meridian Bioscience
- 16.10. OptiGene Limited
- LIST NOT EXHAUSTIVE
- 17. Appendix
- 17.1. About Us and Services
- 17.2. Contact Us
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook